Altimmune Stock (NASDAQ: ALT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 465.000 / 4.731M |
Day Range | - - - |
52 Wk Range | 2.090 - 14.840 |
Market Cap | $547.312M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 25.21% |
Days to Cover | 4.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Altimmune (NASDAQ: ALT) through any online brokerage.
Other companies in Altimmune’s space includes: KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Fate Therapeutics (NASDAQ:FATE).
The latest price target for Altimmune (NASDAQ: ALT) was reported by HC Wainwright & Co. on Monday, April 1, 2024. The analyst firm set a price target for 12.00 expecting ALT to rise to within 12 months (a possible 55.44% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Altimmune (NASDAQ: ALT) is $7.72 last updated Today at April 24, 2024 at 7:00 AM EDT.
There are no upcoming dividends for Altimmune.
Altimmune’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Altimmune.
Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.